<?xml version="1.0" encoding="utf-8"?>
<iati-activities version="2.03" generated-datetime="2026-11-09T09:21:46+00:00">
  <iati-activity last-updated-datetime="2026-11-07T09:53:07+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-BLZ-C-UNDP-1</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Investing for impact against tuberculosis and HIV - Belize (01-Jan-2016-31-Dec-2018)</narrative>
    </title>
    <description type="1">
      <narrative>Belize, TB/HIV, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: To effectively detect and cure all forms of TB, MDR-TB and TB-HIV infections; To halt the spread of HIV and HIV/TB co infections among MSM and other males at risk (sexually active men ages 19-49 years) with a focus on Belize, Stann Creek and Cayo Districts. Objectives: To improve the quality of treatment and care services to persons with HIV, TB and TB/HIV in Belize; To increase the percentage of MSM and other males at risk (sexually active male ages 19-49 years) in BZ, SC, and CY districts who have received an HIV test and know their status.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="BLZ-C-UNDPP01" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2016-01-01" />
    <activity-date type="2" iso-date="2016-01-01" />
    <activity-date type="3" iso-date="2018-12-31" />
    <activity-date type="4" iso-date="2018-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="BZ" percentage="100">
      <narrative>Belize</narrative>
    </recipient-country>
    <sector vocabulary="1" code="13040" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="50">
      <narrative>TB/HIV</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <transaction ref="446045b5-285e-4245-93e6-8cd23f108911">
      <transaction-type code="2" />
      <transaction-date iso-date="2015-09-30" />
      <value currency="USD" value-date="2015-09-30">1891734.00</value>
      <description>
        <narrative>Global Fund commitment to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="275d4d0e-69b8-4af0-9a0d-b8f7f2cfa51e">
      <transaction-type code="3" />
      <transaction-date iso-date="2015-12-10" />
      <value currency="USD" value-date="2015-12-10">1887349.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="386117ed-6f63-4838-b6d3-3ec4224aa703">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-06-30" />
      <value currency="USD" value-date="2017-06-30">-4385.00</value>
      <description>
        <narrative>Global Fund commitment to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="da94df79-2ed9-47b4-90db-5b9dc13dcdd7">
      <transaction-type code="2" />
      <transaction-date iso-date="2017-06-30" />
      <value currency="USD" value-date="2017-06-30">1040059.00</value>
      <description>
        <narrative>Global Fund commitment to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="83e076b1-b8e8-4d6c-b00d-dd0f2d37a245">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-04" />
      <value currency="USD" value-date="2017-07-04">145644.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="101f58d7-17a1-4355-ac87-9191eb16dbbc">
      <transaction-type code="3" />
      <transaction-date iso-date="2017-07-18" />
      <value currency="USD" value-date="2017-07-18">165625.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b557333d-21ad-49b7-9cfd-94427be2a767">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-01-11" />
      <value currency="USD" value-date="2018-01-11">408363.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="e8fce189-6423-4e36-9d67-52ec3ed002ad">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-03-29" />
      <value currency="USD" value-date="2018-03-29">320427.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="b844729d-d72e-4220-8c2a-947680e5eecf">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-05-25" />
      <value currency="USD" value-date="2018-05-25">94285.00</value>
      <description>
        <narrative>Global Fund commitment to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="cdf77b1c-0843-43e5-8677-09a3253f3792">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-09-27" />
      <value currency="USD" value-date="2018-09-27">94285.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="4ce2134e-116f-47f0-8b62-35b0c54f6875">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-17" />
      <value currency="USD" value-date="2018-12-17">26857.46</value>
      <description>
        <narrative>Global Fund commitment to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="0a9f0e14-071f-4782-873a-815ef505543c">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">26857.46</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP01.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/BLZ-C-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="0" />
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="2" />
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="3" />
          <actual value="1" />
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="5" />
          <actual value="0" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
      </title>
      <description>
        <narrative>Module: MDR-TB.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="0" />
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="3" />
          <actual value="0" />
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="5" />
          <actual value="0" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for MSM and TGs.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="13">
          <comment>
            <narrative>Numerator: 300; Denominator: 2312.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="21.6">
            <comment>
              <narrative>Numerator: 550; Denominator: 2551.</narrative>
            </comment>
          </target>
          <actual value="21.2">
            <comment>
              <narrative>Numerator: 540; Denominator: 2551.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="26.7">
            <comment>
              <narrative>Numerator: 700; Denominator: 2618.</narrative>
            </comment>
          </target>
          <actual value="26.7">
            <comment>
              <narrative>Numerator: 699; Denominator: 2618.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of MSM that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for MSM and TGs.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of MSM that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="13">
          <comment>
            <narrative>Numerator: 300; Denominator: 2312.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="18.1">
            <comment>
              <narrative>Numerator: 450; Denominator: 2486.</narrative>
            </comment>
          </target>
          <actual value="18.2">
            <comment>
              <narrative>Numerator: 452; Denominator: 2486.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="21.6">
            <comment>
              <narrative>Numerator: 550; Denominator: 2551.</narrative>
            </comment>
          </target>
          <actual value="22.4">
            <comment>
              <narrative>Numerator: 571; Denominator: 2551.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="26.7">
            <comment>
              <narrative>Numerator: 700; Denominator: 2618.</narrative>
            </comment>
          </target>
          <actual value="26.7">
            <comment>
              <narrative>Numerator: 699; Denominator: 2618.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for other vulnerable populations.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of other vulnerable populations reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="11.6">
          <comment>
            <narrative>Numerator: 5349; Denominator: 46238.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="22.9">
            <comment>
              <narrative>Numerator: 11700; Denominator: 51029.</narrative>
            </comment>
          </target>
          <actual value="21.3">
            <comment>
              <narrative>Numerator: 10919; Denominator: 51209.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="26.7">
            <comment>
              <narrative>Numerator: 14000; Denominator: 52366.</narrative>
            </comment>
          </target>
          <actual value="21.4">
            <comment>
              <narrative>Numerator: 11180; Denominator: 52366.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative>
      </title>
      <description>
        <narrative>Module: Prevention programs for other vulnerable populations.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="11.6">
          <comment>
            <narrative>Numerator: 5349; Denominator: 46238.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="17.1">
            <comment>
              <narrative>Numerator: 8500; Denominator: 49725.</narrative>
            </comment>
          </target>
          <actual value="15">
            <comment>
              <narrative>Numerator: 7469; Denominator: 49725.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="22.9">
            <comment>
              <narrative>Numerator: 11700; Denominator: 51029.</narrative>
            </comment>
          </target>
          <actual value="21.3">
            <comment>
              <narrative>Numerator: 10919; Denominator: 51209.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="26.7">
            <comment>
              <narrative>Numerator: 14000; Denominator: 52366.</narrative>
            </comment>
          </target>
          <actual value="21.4">
            <comment>
              <narrative>Numerator: 11180; Denominator: 52366.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="5" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31">
          <comment>
            <narrative>Numerator: 72.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 73; Denominator: 2897; Percentage: 2.52%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 0; Denominator: 2897; Percentage: 0%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 587; Denominator: 2897; Percentage: 20.26%.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 596; Denominator: 2897; Percentage: 20.57%.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 49.</narrative>
            </comment>
          </target>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 54.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 117.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target>
            <comment>
              <narrative>Numerator: 49.</narrative>
            </comment>
          </target>
          <actual>
            <comment>
              <narrative>Numerator: 99.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 99.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 0.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 37.</narrative>
            </comment>
          </actual>
          <actual>
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 62.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2013" iso-date="2013-12-31" value="59.7">
          <comment>
            <narrative>Numerator: 43; Denominator: 72.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31" value="51.52">
          <dimension name="Age" value="15+" />
          <comment>
            <narrative>Numerator: 17; Denominator: 33.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31" value="3.03">
          <dimension name="Age" value="&lt;15" />
          <comment>
            <narrative>Numerator: 1; Denominator: 33.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31" value="9.09">
          <dimension name="Gender" value="Female" />
          <comment>
            <narrative>Numerator: 3; Denominator: 33.</narrative>
          </comment>
        </baseline>
        <baseline year="2014" iso-date="2014-12-31" value="45.45">
          <dimension name="Gender" value="Male" />
          <comment>
            <narrative>Numerator: 15; Denominator: 33.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="60" />
          <actual value="66.7">
            <comment>
              <narrative>Numerator: 52; Denominator: 78.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="70" />
          <actual value="61.7">
            <comment>
              <narrative>Numerator: 74; Denominator: 120.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="86" />
          <actual value="70.9">
            <comment>
              <narrative>Numerator: 83; Denominator: 117.</narrative>
            </comment>
          </actual>
          <actual value="70.7">
            <dimension name="Age" value="15+" />
            <comment>
              <narrative>Numerator: 82; Denominator: 116.</narrative>
            </comment>
          </actual>
          <actual value="100">
            <dimension name="Age" value="&lt;15" />
            <comment>
              <narrative>Numerator: 1; Denominator: 1.</narrative>
            </comment>
          </actual>
          <actual value="76">
            <dimension name="Gender" value="Female" />
            <comment>
              <narrative>Numerator: 38; Denominator: 50.</narrative>
            </comment>
          </actual>
          <actual value="67.2">
            <dimension name="Gender" value="Male" />
            <comment>
              <narrative>Numerator: 45; Denominator: 67.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
      </title>
      <description>
        <narrative>Module: TB/HIV.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="78.6">
          <comment>
            <narrative>Numerator: 11; Denominator: 14.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="93.3">
            <comment>
              <narrative>Numerator: 28; Denominator: 30.</narrative>
            </comment>
          </target>
          <actual value="96.4">
            <comment>
              <narrative>Numerator: 27; Denominator: 28.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="97.1">
            <comment>
              <narrative>Numerator: 34; Denominator: 35.</narrative>
            </comment>
          </target>
          <actual value="90.3">
            <comment>
              <narrative>Numerator: 28; Denominator: 31.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative.</narrative>
        </description>
        <baseline year="2014" iso-date="2014-12-31" value="40.8">
          <comment>
            <narrative>Numerator: 1183; Denominator: 2897.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2016-01-01" />
          <period-end iso-date="2016-12-31" />
          <target value="42.1">
            <comment>
              <narrative>Numerator: 1343; Denominator: 3191.</narrative>
            </comment>
          </target>
          <actual value="38.9">
            <comment>
              <narrative>Numerator: 1242; Denominator: 3191.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2017-01-01" />
          <period-end iso-date="2017-12-31" />
          <target value="45.3">
            <comment>
              <narrative>Numerator: 1509; Denominator: 3332.</narrative>
            </comment>
          </target>
          <actual value="43.8">
            <comment>
              <narrative>Numerator: 1460; Denominator: 3332.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2018-01-01" />
          <period-end iso-date="2018-12-31" />
          <target value="47.8">
            <comment>
              <narrative>Numerator: 1662; Denominator: 3474.</narrative>
            </comment>
          </target>
          <actual value="42.8">
            <comment>
              <narrative>Numerator: 1486; Denominator: 3474.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
  <iati-activity last-updated-datetime="2026-11-09T09:21:46+00:00" xml:lang="en" default-currency="USD" humanitarian="0" hierarchy="1">
    <iati-identifier>47045-BLZ-C-UNDP-2</iati-identifier>
    <reporting-org ref="47045" type="30">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </reporting-org>
    <title>
      <narrative>Building Resilience Through Innovation and National Accountability - Belize (01-Jan-2019-31-Dec-2021)</narrative>
    </title>
    <description type="1">
      <narrative>Belize, TB/HIV, United Nations Development Programme</narrative>
    </description>
    <description type="2">
      <narrative>Goals: New HIV infections among men who have sex with men account for a maximum of 30% of all new infections; 80% Of persons living with HIV, who are on ART, remain on ART; To promptly find and completely cure 100%  of cases of TB disease, including MDR-TB, while assuring that patients -especially persons living with HIV- benefit from broader preventive care. Objectives: Reduce HIV transmission among the key population groups Men who have sex with men;Trans-gender Women; and Males-At-Risk 15-29 years; The clinical management of 100% of cases of persons on ART includes consistent routine CD4 and Viral Load testing; A 90% reduction in tuberculosis incidence rate (while curing 100% of detected cases); Improve the detection and management of MDR-TB.</narrative>
    </description>
    <participating-org ref="47045" type="30" role="1" crs-channel-code="47045">
      <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
    </participating-org>
    <participating-org type="40" role="2" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <participating-org type="40" role="4" crs-channel-code="41000">
      <narrative>United Nations Development Programme</narrative>
    </participating-org>
    <other-identifier ref="BLZ-C-UNDPP02" type="A1">
      <owner-org ref="47045">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </owner-org>
    </other-identifier>
    <activity-status code="4" />
    <activity-date type="1" iso-date="2019-01-01" />
    <activity-date type="2" iso-date="2019-01-01" />
    <activity-date type="3" iso-date="2021-12-31" />
    <activity-date type="4" iso-date="2021-12-31" />
    <contact-info type="1">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Communications</narrative>
      </department>
      <telephone>+41 58 791 1700</telephone>
      <email>website@theglobalfund.org</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <contact-info type="2">
      <organisation>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </organisation>
      <department>
        <narrative>Grant Management Division</narrative>
      </department>
      <person-name>
        <narrative>xxxx xxxx</narrative>
      </person-name>
      <job-title>
        <narrative>Fund Portfolio Manager</narrative>
      </job-title>
      <telephone>+41 58 791 1700</telephone>
      <email>xxxx</email>
      <website>https://www.theglobalfund.org</website>
      <mailing-address>
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland</narrative>
      </mailing-address>
    </contact-info>
    <activity-scope code="4" />
    <recipient-country code="BZ" percentage="100">
      <narrative>Belize</narrative>
    </recipient-country>
    <sector vocabulary="1" code="12110" percentage="58.19">
      <narrative>Multicomponent, RSSH</narrative>
    </sector>
    <sector vocabulary="1" code="13040" percentage="28.48">
      <narrative>HIV</narrative>
    </sector>
    <sector vocabulary="1" code="12263" percentage="13.33">
      <narrative>Tuberculosis</narrative>
    </sector>
    <tag vocabulary="2" code="3">
      <narrative>Ensure healthy lives and promote well-being for all at all ages</narrative>
    </tag>
    <tag vocabulary="3" code="3.3">
      <narrative>End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases</narrative>
    </tag>
    <tag vocabulary="3" code="3.8">
      <narrative>Achieve universal health coverage</narrative>
    </tag>
    <country-budget-items vocabulary="4">
      <budget-item code="7e4b93f2-44a8-439d-b8e5-143be7b5aa27" percentage="8.2">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for MSM -&gt; Behavioral interventions for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="1cf647b8-2d58-48ad-9cc9-b479690cb394" percentage="7.13">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for MSM -&gt; HIV testing services for MSM</narrative>
        </description>
      </budget-item>
      <budget-item code="dcb7435c-68dd-4f9b-a422-0fd44e268fc1" percentage="1.06">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for TGs -&gt; Behavioral interventions for TGs</narrative>
        </description>
      </budget-item>
      <budget-item code="baada981-4aeb-4243-8955-ccd921e4d1cd" percentage="0.21">
        <description>
          <narrative>HIV -&gt; Comprehensive prevention programs for TGs -&gt; HIV testing services for TGs</narrative>
        </description>
      </budget-item>
      <budget-item code="f656ae4a-0f86-4a63-bf7a-8dce1eda4edd" percentage="0.11">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; HIV and HIV/TB-related legal services</narrative>
        </description>
      </budget-item>
      <budget-item code="557c641d-d721-482b-a47f-096caa882957" percentage="0.58">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Human rights and medical ethics related to HIV and HIV/TB for health care providers</narrative>
        </description>
      </budget-item>
      <budget-item code="58c0b914-97aa-48f7-a852-b18c3835a345" percentage="1.01">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Improving laws, regulations and policies relating to HIV and HIV/TB</narrative>
        </description>
      </budget-item>
      <budget-item code="48484293-8d88-4a4d-ac0d-6ea012152220" percentage="0.18">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Sensitization of law-makers and law-enforcement agents</narrative>
        </description>
      </budget-item>
      <budget-item code="27cc825e-cdd6-4725-8a33-53f5a933b287" percentage="0.17">
        <description>
          <narrative>HIV -&gt; Reducing human rights-related barriers to HIV/TB services -&gt; Stigma and discrimination reduction (HIV/TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="a641d0ba-c0a0-4c16-b6a7-67f84f442628" percentage="4.9">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment adherence</narrative>
        </description>
      </budget-item>
      <budget-item code="01ef4c05-d90c-45d3-9465-bf425efdc645" percentage="2">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Drug resistance</narrative>
        </description>
      </budget-item>
      <budget-item code="c7d050d8-ddb8-42db-a948-04038ae9cd0f" percentage="2.92">
        <description>
          <narrative>HIV -&gt; Treatment, care and support -&gt; Treatment monitoring - Viral load</narrative>
        </description>
      </budget-item>
      <budget-item code="955f4722-71fb-4b46-8bd2-2d741fdad76b" percentage="2.47">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Coordination and management of national disease control programs</narrative>
        </description>
      </budget-item>
      <budget-item code="e07bbbe4-54fa-4084-a6fe-7f1c9c3b77b6" percentage="35.57">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Grant management</narrative>
        </description>
      </budget-item>
      <budget-item code="2e778829-d9f6-4382-b52a-31c55a719622" percentage="6.11">
        <description>
          <narrative>Multicomponent -&gt; Program management -&gt; Other program management intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="04ad0584-b1dd-4ef6-ac1e-dad3669a97d1" percentage="3.33">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Institutional capacity building, planning and leadership development</narrative>
        </description>
      </budget-item>
      <budget-item code="3e9642ae-693f-47d9-95b3-3cf2c3e2e170" percentage="0.6">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Other community responses and systems intervention(s)</narrative>
        </description>
      </budget-item>
      <budget-item code="2c00622f-0877-4553-993e-389582dbbfd1" percentage="0.22">
        <description>
          <narrative>RSSH -&gt; RSSH: Community systems strengthening -&gt; Social mobilization, building community linkages and coordination</narrative>
        </description>
      </budget-item>
      <budget-item code="c9a33ca8-7a81-4232-9a19-1315956af36c" percentage="0.53">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Analysis, evaluations, reviews and transparency</narrative>
        </description>
      </budget-item>
      <budget-item code="004842a6-d6eb-49a2-a763-882fd356689a" percentage="0.12">
        <description>
          <narrative>RSSH -&gt; RSSH: Health management information systems and M&amp;E -&gt; Program and data quality</narrative>
        </description>
      </budget-item>
      <budget-item code="054acddf-7eaa-4d8d-b6a4-97e7f6a59a1e" percentage="1.3">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Capacity building for health workers, including those at community level</narrative>
        </description>
      </budget-item>
      <budget-item code="a9a15642-9d30-4ac6-85fe-0d687727c2d2" percentage="7.95">
        <description>
          <narrative>RSSH -&gt; RSSH: Human resources for health, including community health workers -&gt; Retention and scale-up of health workers, including for community health workers</narrative>
        </description>
      </budget-item>
      <budget-item code="1c7b99cb-f18c-499f-a55d-f7a0d6b99b21" percentage="2.21">
        <description>
          <narrative>Tuberculosis -&gt; MDR-TB -&gt; Case detection and diagnosis (MDR-TB)</narrative>
        </description>
      </budget-item>
      <budget-item code="f7014493-22e9-4c03-96d0-144fbb3a254f" percentage="0.42">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Case detection and diagnosis (TB care and prevention)</narrative>
        </description>
      </budget-item>
      <budget-item code="a0ec8795-341f-4d7b-9bdd-618cfc782127" percentage="4.95">
        <description>
          <narrative>Tuberculosis -&gt; TB care and prevention -&gt; Community TB care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="755fd9d3-5219-420f-8cf5-d32af32e5180" percentage="2.21">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; Community TB/HIV care delivery</narrative>
        </description>
      </budget-item>
      <budget-item code="92e11022-488c-4948-abb3-b61f3d9ca4f6" percentage="3.54">
        <description>
          <narrative>Tuberculosis -&gt; TB/HIV -&gt; TB/HIV - Collaborative interventions</narrative>
        </description>
      </budget-item>
    </country-budget-items>
    <collaboration-type code="1" />
    <default-flow-type code="10" />
    <default-finance-type code="110" />
    <default-aid-type code="C01" vocabulary="1" />
    <default-tied-status code="5" />
    <budget type="2" status="2">
      <period-start iso-date="2019-01-01" />
      <period-end iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-01-01">574272.11</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2020-01-01" />
      <period-end iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-01-01">686046.85</value>
    </budget>
    <budget type="2" status="2">
      <period-start iso-date="2021-01-01" />
      <period-end iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-01-01">1410774.92</value>
    </budget>
    <capital-spend percentage="6.37" />
    <transaction ref="4000aa15-2382-4e82-9bae-77b9b9655e06">
      <transaction-type code="2" />
      <transaction-date iso-date="2018-12-17" />
      <value currency="USD" value-date="2018-12-17">1035991.00</value>
      <description>
        <narrative>Global Fund commitment to BLZ-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="2c0e7372-bc82-435f-b298-93e021953991">
      <transaction-type code="3" />
      <transaction-date iso-date="2018-12-18" />
      <value currency="USD" value-date="2018-12-18">198569.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="becc7b5f-68ee-495a-bb27-ac910d982736">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-03-29" />
      <value currency="USD" value-date="2019-03-29">215117.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="51ea1d6e-e4d9-418e-8f6f-ae3f0b1013d2">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-07-02" />
      <value currency="USD" value-date="2019-07-02">136815.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0e2c7ee9-a0c6-4c9e-a8f1-5d170b817f7e">
      <transaction-type code="3" />
      <transaction-date iso-date="2019-10-01" />
      <value currency="USD" value-date="2019-10-01">138245.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8d665473-f497-4963-a3ea-09ee35d8842a">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-01-10" />
      <value currency="USD" value-date="2020-01-10">186271.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="9deb9742-28d7-4b6f-be28-65a3148d42e5">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-04-02" />
      <value currency="USD" value-date="2020-04-02">160974.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="0ddc6a60-f5a2-4ad6-b524-adf29da6eb99">
      <transaction-type code="2" />
      <transaction-date iso-date="2020-05-28" />
      <value currency="USD" value-date="2020-05-28">602857.60</value>
      <description>
        <narrative>Global Fund commitment to BLZ-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="ca241892-63a6-4e99-ab3a-9f9c53a7fb9a">
      <transaction-type code="3" />
      <transaction-date iso-date="2020-06-09" />
      <value currency="USD" value-date="2020-06-09">237219.85</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="d7269df4-82a3-425f-a9e0-cbd09305a320">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-01-06" />
      <value currency="USD" value-date="2021-01-06">211945.17</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="07f19d53-36fd-4317-8b91-35a921d6c9f9">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-02" />
      <value currency="USD" value-date="2021-04-02">153692.58</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="8cb64203-a264-407d-86cd-8d9c92695d41">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-04-17" />
      <value currency="USD" value-date="2021-04-17">430747.67</value>
      <description>
        <narrative>Global Fund commitment to BLZ-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="bf70d53a-57f0-4e40-a14c-313d495e6fb8">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-04-30" />
      <value currency="USD" value-date="2021-04-30">430747.67</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="921a5e4c-8d50-44c9-89bd-8517e14cb041">
      <transaction-type code="2" />
      <transaction-date iso-date="2021-10-13" />
      <value currency="USD" value-date="2021-10-13">526486.00</value>
      <description>
        <narrative>Global Fund commitment to BLZ-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="e7cb7383-bbb1-4e32-bbb4-42cc8cb2c6ca">
      <transaction-type code="3" />
      <transaction-date iso-date="2021-10-21" />
      <value currency="USD" value-date="2021-10-21">526486.00</value>
      <description>
        <narrative>Global Fund disbursement to BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
      <disbursement-channel code="2" />
    </transaction>
    <transaction ref="05e9478a-f4c8-43c0-a808-2442e808c7eb">
      <transaction-type code="7" />
      <transaction-date iso-date="2023-04-19" />
      <value currency="USD" value-date="2023-04-19">624.48</value>
      <description>
        <narrative>Funds returned to the Global Fund from BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="315dba03-af8e-4173-ad9f-66c9b2c1a60c">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-04-24" />
      <value currency="USD" value-date="2023-04-24">-624.48</value>
      <description>
        <narrative>Global Fund commitment to BLZ-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="f9bc749b-6c6e-4f41-ae20-de442c6afed2">
      <transaction-type code="2" />
      <transaction-date iso-date="2023-04-24" />
      <value currency="USD" value-date="2023-04-24">-110459.03</value>
      <description>
        <narrative>Global Fund commitment to BLZ-C-UNDPP02.</narrative>
      </description>
      <provider-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </provider-org>
      <receiver-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="479e82a4-07ed-4373-bec2-96fa4f403732">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">104094.00</value>
      <description>
        <narrative>Funds returned to the Global Fund from BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="5d18ed27-3d43-4732-b643-27e3326baea9">
      <transaction-type code="7" />
      <transaction-date iso-date="2025-10-01" />
      <value currency="USD" value-date="2025-10-01">6365.03</value>
      <description>
        <narrative>Funds returned to the Global Fund from BLZ-C-UNDPP02 (Multilateral).</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
      <receiver-org ref="47045" type="30">
        <narrative>The Global Fund to Fight AIDS, Tuberculosis and Malaria</narrative>
      </receiver-org>
    </transaction>
    <transaction ref="BLZ-C-UNDPP02-EXP-20191231">
      <transaction-type code="4" />
      <transaction-date iso-date="2019-12-31" />
      <value currency="USD" value-date="2019-12-31">574272.00</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for BLZ-C-UNDPP02, Jan 2019 to Dec 2019.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="BLZ-C-UNDPP02-EXP-20201231">
      <transaction-type code="4" />
      <transaction-date iso-date="2020-12-31" />
      <value currency="USD" value-date="2020-12-31">686046.85</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for BLZ-C-UNDPP02, Jan 2020 to Dec 2020.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="BLZ-C-UNDPP02-EXP-20211231">
      <transaction-type code="4" />
      <transaction-date iso-date="2021-12-31" />
      <value currency="USD" value-date="2021-12-31">838923.48</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for BLZ-C-UNDPP02, Jan 2021 to Dec 2021.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <transaction ref="BLZ-C-UNDPP02-EXP-20220930">
      <transaction-type code="4" />
      <transaction-date iso-date="2022-09-30" />
      <value currency="USD" value-date="2022-09-30">447727.86</value>
      <description>
        <narrative>Expenditure reported by United Nations Development Programme for BLZ-C-UNDPP02, Jan 2022 to Sep 2022.</narrative>
      </description>
      <provider-org type="40">
        <narrative>United Nations Development Programme</narrative>
      </provider-org>
    </transaction>
    <document-link url="https://data.theglobalfund.org/grant/BLZ-C-UNDP" format="text/html">
      <title>
        <narrative>Grant page on the data explorer of the Global Fund.</narrative>
      </title>
      <description>
        <narrative>An overview of a grant over its lifetime.</narrative>
      </description>
      <category code="A12" />
      <category code="A01" />
      <category code="A02" />
      <category code="A05" />
      <category code="A07" />
      <category code="A08" />
      <language code="en" />
      <document-date iso-date="2026-11-09" />
    </document-link>
    <document-link url="https://www.theglobalfund.org/media/13342/core_grantregulationsversiontwo_regulations_en.pdf" format="application/pdf">
      <title>
        <narrative>Grant terms and conditions.</narrative>
      </title>
      <description>
        <narrative>General terms and conditions which apply to Global Fund grants.</narrative>
      </description>
      <category code="A04" />
      <language code="en" />
    </document-link>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
      </title>
      <description>
        <narrative>Module: Comprehensive prevention programs for MSM.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: Subnational. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="21.17">
          <comment>
            <narrative>Numerator: 540; Denominator: 2551.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="29">
            <comment>
              <narrative>Numerator: 1058; Denominator: 3689.</narrative>
            </comment>
          </target>
          <actual value="28.2">
            <comment>
              <narrative>Numerator: 1040; Denominator: 3689.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="37.92">
            <comment>
              <narrative>Numerator: 1424; Denominator: 3755.</narrative>
            </comment>
          </target>
          <actual value="42.5">
            <comment>
              <narrative>Numerator: 1595; Denominator: 3755.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="49.7">
            <comment>
              <narrative>Numerator: 1900; Denominator: 3823.</narrative>
            </comment>
          </target>
          <actual value="48.7">
            <comment>
              <narrative>Numerator: 1860; Denominator: 3823.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="1" aggregation-status="0">
        <title>
          <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2017" iso-date="2017-12-31" value="117" />
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="120" />
          <actual value="91" />
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="95" />
          <actual value="81" />
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="95" />
          <actual value="72" />
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
      </title>
      <description>
        <narrative>Module: TB care and prevention.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Treatment success rate- all forms: Percentage of TB cases, all forms, bacteriologically confirmed plus clinically diagnosed, successfully treated (cured plus treatment completed) among all TB cases registered for treatment during a specified period, new and relapse cases</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Cumulative annually.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="61.67">
          <comment>
            <narrative>Numerator: 74; Denominator: 120.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="70" />
          <actual value="63.6">
            <comment>
              <narrative>Numerator: 63; Denominator: 99.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="77.5" />
          <actual value="70.3">
            <comment>
              <narrative>Numerator: 64; Denominator: 91.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="85" />
          <actual value="81.5">
            <comment>
              <narrative>Numerator: 66; Denominator: 81.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
    <result type="1" aggregation-status="0">
      <title>
        <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
      </title>
      <description>
        <narrative>Module: Treatment, care and support.</narrative>
      </description>
      <indicator measure="2" aggregation-status="0">
        <title>
          <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative>
        </title>
        <description>
          <narrative>Geographic coverage: National. Aggregation: Non cumulative - other.</narrative>
        </description>
        <baseline year="2016" iso-date="2016-12-31" value="30.84">
          <comment>
            <narrative>Numerator: 1354; Denominator: 4391.</narrative>
          </comment>
        </baseline>
        <period>
          <period-start iso-date="2019-01-01" />
          <period-end iso-date="2019-12-31" />
          <target value="54.6">
            <comment>
              <narrative>Numerator: 2550; Denominator: 4671.</narrative>
            </comment>
          </target>
          <actual value="32.8">
            <comment>
              <narrative>Numerator: 1530; Denominator: 4671.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2020-01-01" />
          <period-end iso-date="2020-12-31" />
          <target value="63.07">
            <comment>
              <narrative>Numerator: 3050; Denominator: 4836.</narrative>
            </comment>
          </target>
          <actual value="30.8">
            <comment>
              <narrative>Numerator: 1490; Denominator: 4836.</narrative>
            </comment>
          </actual>
        </period>
        <period>
          <period-start iso-date="2021-01-01" />
          <period-end iso-date="2021-12-31" />
          <target value="69.78">
            <comment>
              <narrative>Numerator: 3500; Denominator: 5016.</narrative>
            </comment>
          </target>
          <actual value="39.4">
            <comment>
              <narrative>Numerator: 1626; Denominator: 4124.</narrative>
            </comment>
          </actual>
        </period>
      </indicator>
    </result>
  </iati-activity>
</iati-activities>